Zuellig Pharma Korea (ZPK) announced of its financial performance results for Year 2004, in which the company reported the sales of 22.9 billion won, up by 6.1% from the prior fiscal period.
From the results announced, the company's operating profit is reported at 1.1 billion won, which shows an increase of 229% on a year-over-year basis, and the company reported losses in both the ordinary ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.